Future studies should aim to elucidate the mechanistic links between EIF2S1 and immune regulation in NB, potentially uncovering new avenues for combination therapies that target both EIF2S1 and immune-related pathways. This evidence concerns the gene EIF2S1 and neuroblastoma.